TOCA - Tocagen: Free Ticket For Run-Up Ride
Editor's note: Seeking Alpha is proud to welcome Tridobe Biotech Investment as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more »
On May 21, Tocagen (TOCA) announced that the Toca 5 Phase 3 clinical trial evaluating Toca 511 & Toca FC with recurrent high grade glioma ((HGG)) continues without modification, following the suggestion from IDMC based on the second interim analysis. The shares are down 53% afterwards. But does